TB

This report summarizes the accomplishments and activities of the Stop TB Partnership in 2011.

Although guidelines for population-based TB disease prevalence surveys exist, these cannot readily be used for measuring the prevalence of TB disease among health care workers, specific adaptations are needed. This guide is intended to provide that guidance for the specific setting of health care workers. This guide is designed to be used in combination with the WHO TB Prevalence Surveys: A Handbook.

This document lists the essential research questions that will provide a common framework for various scientific disciplines to work concurrently and collaboratively towards better TB control and elimination.

Dr. Kenneth Castro explains why it is important for people living with HIV to be tested for TB.

This brochure was developed for clinicians to use with patients while discussing the 12-dose regimen. The brochure contains information on latent TB infection, the 12-dose regimen, treatment schedules, and adverse events. There is space on this brochure to write in treatment schedules and clinic/office contact information.

The MDR-TB Planning Toolkit is designed to help assist countries develop or strengthen a multidrug-resistant tuberculosis (MDR-TB) component within their national TB strategy or plan. Eight tools contain worksheets to assist the user through key planning steps. The toolkit is intended for countries, technical partners, international organizations, and donors.

The main purpose of this guide is to describe and explain how to design, implement and analyse an inventory study to measure TB under-reporting. The guide also explains how to apply capture-recapture methods to estimate TB incidence, emphasizing the conditions that must be fulfilled for these methods to be used. This guide is intended for use by NTP managers, researchers including epidemiologists and statisticians, and agencies that provide financial and technical support for inventory studies.

In this video, Dr. Caralee Caplan-Shaw and her patients clarify the risks of untreated latent TB infection and motivate your patients to complete treatment.

The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing. 

This pocket-sized card for clinicians provides information on identifying those at risk for TB. The resource also includes content on latent TB infection testing, diagnosis, and treatment in adults.